scispace - formally typeset
Journal ArticleDOI

A comprehensive review of SHP2 and its role in cancer

Moges Dessale Asmamaw, +3 more
- 06 Sep 2022 - 
- Vol. 45, Iss: 5, pp 729-753
Reads0
Chats0
TLDR
About
This article is published in Cellular oncology.The article was published on 2022-09-06. It has received 17 citations till now. The article focuses on the topics: Medicine & Biology.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

SH2 Domains: Folding, Binding and Therapeutical Approaches

TL;DR: In this paper , the structural, folding stability, and binding properties of SH2 domains and their roles in molecular pathways and pathogenesis are summarized and different strategies employed to modulate/inhibit SH2 domain binding.
Journal ArticleDOI

Allostery Frustrates the Experimentalist

TL;DR: The concept of allostery was broadened to encompass all types of long-range interactions across a protein including purely entropic changes without a conformational change in single protein domains as mentioned in this paper .
Journal ArticleDOI

Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2

TL;DR: The role of protein tyrosine phosphatase (PTPN11) variants in rare diseases and advances in the understanding of its pathogenesis using model systems are discussed in this article .
Journal ArticleDOI

Experiment-guided molecular simulations define a heterogeneous structural ensemble for the PTPN11 tandem SH2 domains

TL;DR: In this paper , the structural ensemble of the tandem SH2 in solution was determined using experiment-guided molecular simulations, in agreement with experimental data from small-angle X-ray scattering and NMR residual dipolar couplings.
Journal ArticleDOI

Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review

TL;DR: Wang et al. as mentioned in this paper examined the PD-1/PD-L1 axis and its role in tumor immune escape while exploring how TCM therapies can modulate the PD 1/PD L 1 axis to improve the efficacy of cancer immunotherapy.
References
More filters
Journal ArticleDOI

Cell signaling by receptor-tyrosine kinases

TL;DR: Understanding of the complex signaling networks downstream from RTKs and how alterations in these networks are translated into cellular responses provides an important context for therapeutically countering the effects of pathogenic RTK mutations in cancer and other diseases.
Journal ArticleDOI

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Roger E. McLendon, +233 more
- 23 Oct 2008 - 
TL;DR: The interim integrative analysis of DNA copy number, gene expression and DNA methylation aberrations in 206 glioblastomas reveals a link between MGMT promoter methylation and a hypermutator phenotype consequent to mismatch repair deficiency in treated gliobeasts, demonstrating that it can rapidly expand knowledge of the molecular basis of cancer.
Journal ArticleDOI

Microenvironmental regulation of tumor progression and metastasis.

TL;DR: The paradoxical roles of the tumor microenvironment during specific stages of cancer progression and metastasis are discussed, as well as recent therapeutic attempts to re-educate stromal cells within the TME to have anti-tumorigenic effects.
Journal ArticleDOI

PD-1 and its ligands in tolerance and immunity

TL;DR: Current understanding of the immunoregulatory functions of PD-1 and its ligands and their therapeutic potential are discussed and an inhibitory bidirectional interaction between PD-L1 and B7-1 is discovered, revealing new ways the B7:CD28 family regulates T cell activation and tolerance.
Journal ArticleDOI

The Nuclear Factor NF-κB Pathway in Inflammation

TL;DR: How genetic evidence in mice has revealed complex roles for the NF-kappaB in inflammation that suggest both pro- and anti-inflammatory roles for this pathway is described.
Related Papers (5)